Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03246490 · ClinicalTrials.gov registry record · NA
A Machine Learning Approach for Inferring Alcohol Intoxication Levels From Gait Data
A NA study, sponsored by Butler Hospital.
- Completed
- Registry status
- NA
- Development phase
- 141
- Enrollment target
NCT03246490: Completed NA study, sponsored by Butler Hospital.
NCT03246490 is a NA study that has completed, run by Butler Hospital. The registered enrollment target is 141 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03246490, a NA study, has completed, sponsored by Butler Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 141 participants
- Enrollment target
Study Summary
This study aims to develop a phone app to assess gait differences at different levels of alcohol intoxication.
Primary Outcome
a phone app to compare gait changes with blood alcohol levels will be developed based on participant's gait during alcohol use
Interventions
- OTHER All Participants
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2017-12-12 |
| Est. Completion | 2019-07-31 |
| Phase | NA |
What the finished NCT03246490 record still lists
NCT03246490 is an interventional study that assigns participants to a tested intervention. The registered 141 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which All Participants is the first listed.
NCT03246490 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03246490 about?
NCT03246490 is a clinical study titled "A Machine Learning Approach for Inferring Alcohol Intoxication Levels From Gait Data". This study aims to develop a phone app to assess gait differences at different levels of alcohol intoxication.
What is the current status of trial NCT03246490?
This trial is currently completed. It is a NA study. The enrollment target is 141 participants. The study started on 2017-12-12. Estimated completion is 2019-07-31.
What interventions are being tested in trial NCT03246490?
The interventions under investigation include: All Participants (OTHER).
Who is sponsoring clinical trial NCT03246490?
This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03246490's enrollment target sits among peer trials
141 712th of 2000 higher than 1,288 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03042962 · 141 participants
Brain Networks in Dystonia
- NCT04378439 · 141 participants · NA
Appalachian Partnership to Reduce Disparities (Aim 2)
- NCT04775485 · 141 participants · Phase 2
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
- NCT05040360 · 141 participants · Phase 2
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI